Dudediligence.

Immunic, Inc

IMUXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$24.4MSep ’24−$25.2MDec ’24−$25.5MMar ’25−$26.8MJun ’25−$25.6MSep ’25−$19.3MDec ’25−$32.6MMar ’26−$34.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$91.7M−$119.5M−$99.2M−$98.1M−$103.2M
Net income−$92.9M−$120.4M−$93.6M−$100.5M−$97.2M
Operating cash flow−$83.2M−$65.1M−$70.8M−$84.8M−$85.8M
Free cash flow−$83.3M−$65.3M−$71.2M−$85.0M−$86.0M
Cash$86.9M$106.7M$46.7M$35.7M$15.5M
Shares outstanding26.3M39.3M45.2M90.2M90.2M